107.522 articles found

[Treatment of Parkinson's disease by cell transplantation]

Cesaro P.

Rev Neurol (Paris) · 2002-01-01

PMID: 12690325

Management of Parkinson's disease.

Colcher A.

Expert Rev Neurother · 2002-01-01

DOI: 10.1586/14737175.2.1.97PMID: 19811019

Adverse effects in the treatment of Parkinson's disease.

Singer C.

Expert Rev Neurother · 2002-01-01

DOI: 10.1586/14737175.2.1.105PMID: 19811020

Fluvoxamine for the treatment of depression and parkinsonism in progressive supranuclear palsy.

Miyaoka T, Seno H, Inagaki T, Horiguchi J.

Int J Psychiatry Clin Pract · 2002-01-01

DOI: 10.1080/136515002753489416PMID: 24931891

Article Commentary: Cell Transplantation for Parkinson's Disease.

Emerich DF.

Cell Transplant · 2002-01-01

DOI: 10.3727/096020198389726PMID: 28866913

Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.

Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM.

Science · 2001-12-20

DOI: 10.1126/science.1067389PMID: 11823645

Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein.

Cole NB, Murphy DD, Grider T, Rueter S, Brasaemle D, Nussbaum RL.

J Biol Chem · 2001-12-14

DOI: 10.1074/jbc.m108414200PMID: 11744721

Movement initiation device used in Parkinson's disease and other disorders which affect muscle control

MCLOUL RAPHAEL FIFO, OBERMAN CARYN.

· 2001-12-13

Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism.

Wszolek ZK, Gwinn-Hardy K, Wszolek EK, Muenter MD, Pfeiffer RF, Rodnitzky RL, Uitti RJ, McComb RD, Gasser T, Dickson DW.

Acta Neuropathol · 2001-12-08

DOI: 10.1007/s00401-001-0474-8PMID: 11904753

Mechanisms of cognitive set flexibility in Parkinson's disease.

Cools R, Barker RA, Sahakian BJ, Robbins TW.

Brain · 2001-12-01

DOI: 10.1093/brain/124.12.2503PMID: 11701603

Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands.

Cools R, Barker RA, Sahakian BJ, Robbins TW.

Cereb Cortex · 2001-12-01

DOI: 10.1093/cercor/11.12.1136PMID: 11709484

Deactivation of thalamocortical activity is responsible for suppression of parkinsonian tremor by thalamic stimulation: a 99mTc-ECD SPECT study.

Wielepp JP, Burgunder JM, Pohle T, Ritter EP, Kinser JA, Krauss JK.

Clin Neurol Neurosurg · 2001-12-01

DOI: 10.1016/s0303-8467(01)00165-2PMID: 11714567